High tuberculosis exposure among neonates in a high tuberculosis and human immunodeficiency virus burden setting

A Bekker1, K Du Preez, H S Schaaf

  • 1Division of Neonatology, Department of Paediatrics and Child Health, Faculty of Health Science, Stellenbosch University, Cape Town, South Africa. adrie@sun.ac.za

Insights

Maternal tuberculosis (TB) significantly impacts neonatal screening, especially in HIV-prevalent areas. Improving TB care for mothers and infants is crucial for high-burden settings.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Neonatal Care

Background:

  • Maternal and neonatal tuberculosis (TB) are often underdiagnosed, particularly in regions with high human immunodeficiency virus (HIV) prevalence.
  • The co-occurrence of TB and HIV presents unique challenges in maternal and infant healthcare.

Purpose of the Study:

  • To evaluate the outcomes of routine tuberculosis screening in neonates in a South African hospital.
  • To identify the primary indications for neonatal TB screening and assess interventions provided.

Main Methods:

  • A retrospective audit was conducted on neonates screened for TB in 2009.
  • Data were collected from clinical, laboratory, and pharmacy records.

Main Results:

  • Of 70 neonates screened, 60% were HIV-exposed. Maternal TB was the most common exposure (59%).
  • Among 50 neonates exposed to maternal TB, 16% were diagnosed with TB.
  • Interventions included TB chemoprophylaxis (72%), TB treatment (10%), and no intervention (18%).

Conclusions:

  • Maternal TB, especially in HIV-infected women, is a key reason for neonatal TB screening.
  • Enhanced routine screening of pregnant women and integrated TB care for mothers and infants are recommended in high TB/HIV burden settings.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...